Article info

Download PDFPDF
What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus

Authors

  • Maud Lemoine Department of Surgery and Cancer, Hepatology Section, St Mary’s Hospital, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • Hans L Tillmann Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA Gastroenterology and Hepatology, Specialty Clinics, Greenville VA Health Care Center, Greenville, North Carolina, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Maud Lemoine, Department of Surgery and Cancer, Hepatology Section, St Mary’s Hospital, London W2 1NY, UK; m.lemoine{at}imperial.ac.uk
View Full Text

Citation

Lemoine M, Tillmann HL
What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? ‘Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus

Publication history

  • Received May 4, 2018
  • Revised May 10, 2018
  • Accepted May 10, 2018
  • First published June 29, 2018.
Online issue publication 
October 08, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.